Safety and Performance Assessment of Drug-Eluting Stent CRE8 in Diabetic Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 1200
Summary
- Conditions
- Coronaropathy
- Diabetes
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03842813
- Collaborators
- EVAMED
- Investigators
- Study Chair: Julien Vandenwildenberg Alvimedica Medical France
Get Well Soon